| scholarly article | Q13442814 |
| P50 | author | Jiawang Liu | Q91515065 |
| P2093 | author name string | Maryam Foroozesh | |
| Navneet Goyal | |||
| Jayalakshmi Sridhar | |||
| P2860 | cites work | Human enzymes involved in the metabolic activation of carcinogenic aristolochic acids: evidence for reductive activation by cytochromes P450 1A1 and 1A2 | Q24291576 |
| Adaptations for the oxidation of polycyclic aromatic hydrocarbons exhibited by the structure of human P450 1A2 | Q24297785 | ||
| Human Cytochrome P450 1A1 Structure and Utility in Understanding Drug and Xenobiotic Metabolism | Q27676875 | ||
| Inhibition selectivity of grapefruit juice components on human cytochromes P450 | Q28138726 | ||
| Human CYP1A2: sequence, gene structure, comparison with the mouse and rat orthologous gene, and differences in liver 1A2 mRNA expression | Q28258522 | ||
| Specific covalent labeling of cytochrome P-450CAM with 1-(4-azidophenyl)imidazole, an inhibitor-derived photoaffinity probe for P-450 heme proteins | Q28327199 | ||
| Mechanisms of enzyme-catalyzed reduction of two carcinogenic nitro-aromatics, 3-nitrobenzanthrone and aristolochic acid I: Experimental and theoretical approaches | Q28390347 | ||
| Relative imbalances in estrogen metabolism and conjugation in breast tissue of women with carcinoma: potential biomarkers of susceptibility to cancer | Q28611192 | ||
| Metabolic activation of polycyclic aromatic hydrocarbons and other procarcinogens by cytochromes P450 1A1 and P450 1B1 allelic variants and other human cytochromes P450 in Salmonella typhimurium NM2009 | Q28645939 | ||
| Comparative proteomics among cytochrome p450 family 1 for differential substrate specificity. | Q30367970 | ||
| Characterization of differences in substrate specificity among CYP1A1, CYP1A2 and CYP1B1: an integrated approach employing molecular docking and molecular dynamics simulations. | Q30384916 | ||
| Contributions of human enzymes in carcinogen metabolism | Q30520640 | ||
| Organization of the CYP1A cluster on human chromosome 15: implications for gene regulation | Q30981127 | ||
| Summary of information on human CYP enzymes: human P450 metabolism data | Q32103802 | ||
| Cytochrome P450 CYP1A1: wider roles in cancer progression and prevention | Q33468680 | ||
| Furafylline is a potent and selective inhibitor of cytochrome P450IA2 in man. | Q34037250 | ||
| Characterization of the oxidative metabolites of 17beta-estradiol and estrone formed by 15 selectively expressed human cytochrome p450 isoforms | Q34214631 | ||
| Induction of microsomal enzymes by foreign chemicals and carcinogenesis by polycyclic aromatic hydrocarbons: G. H. A. Clowes Memorial Lecture. | Q34270623 | ||
| Metabolic activation of polycyclic aromatic hydrocarbons to carcinogens by cytochromes P450 1A1 and 1B1. | Q34289529 | ||
| Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians. | Q34330493 | ||
| Cytochrome P450 activation of arylamines and heterocyclic amines | Q34410418 | ||
| Cytochrome P450 family 1 inhibitors and structure-activity relationships | Q34436975 | ||
| Structure-activity relationship for human cytochrome P450 substrates and inhibitors | Q34627917 | ||
| Pyranoflavones: a group of small-molecule probes for exploring the active site cavities of cytochrome P450 enzymes 1A1, 1A2, and 1B1. | Q34677757 | ||
| Structure, function, regulation and polymorphism and the clinical significance of human cytochrome P450 1A2. | Q35015993 | ||
| Substrate SARs in human P450s | Q35053188 | ||
| Estimation of the binding modes with important human cytochrome P450 enzymes, drug interaction potential, pharmacokinetics, and hepatotoxicity of ginger components using molecular docking, computational, and pharmacokinetic modeling studies | Q35113280 | ||
| Tizanidine is mainly metabolized by cytochrome p450 1A2 in vitro | Q35825963 | ||
| Targeting cytochrome P450 enzymes: a new approach in anti-cancer drug development | Q35962274 | ||
| CoMFA and molecular docking studies of benzoxazoles and benzothiazoles as CYP450 1A1 inhibitors. | Q50575277 | ||
| Combined Docking and Quantum Chemical Study on CYP-Mediated Metabolism of Estrogens in Man. | Q51266951 | ||
| Docking and QSAR comparative studies of polycyclic aromatic hydrocarbons and other procarcinogen interactions with cytochromes P450 1A1 and 1B1. | Q51479490 | ||
| Modification of cytochrome P450 1A2 enzymes by the mechanism-based inactivator 2-ethynylnaphthalene and the photoaffinity label 4-azidobiphenyl | Q67570953 | ||
| Azidowarfarin photoaffinity probes of purified rat liver cytochrome P4501A1 | Q68077257 | ||
| Hydroperoxysterols as a probe for the mechanism of cytochrome P-450scc-mediated hydroxylation. Homolytic versus heterolytic oxygen-oxygen bond scission | Q69996323 | ||
| Further studies of the suicide inactivation of purified rat liver cytochrome P-450 by chloramphenicol | Q70490462 | ||
| Identification and characterization of cytochrome P4501A1 amino acid residues interacting with a radiolabeled photoaffinity diazido-benzphetamine analogue | Q71126712 | ||
| Evidence for a homolytic mechanism of peroxide oxygen--oxygen bond cleavage during substrate hydroxylation by cytochrome P-450 | Q71401279 | ||
| Molecular modelling of CYP1A subfamily members based on an alignment with CYP102: rationalization of CYP1A substrate specificity in terms of active site amino acid residues | Q71563292 | ||
| Isoform-selective mechanism-based inhibition of human cytochrome P450 1A2 by furafylline | Q72735101 | ||
| Quantitative structure--activity relationships for inducers of cytochromes P450 and nuclear receptor ligands involved in P450 regulation within the CYP1, CYP2, CYP3 and CYP4 families | Q74293634 | ||
| The photolysis of diazoacetylchymotrypsin | Q79419873 | ||
| The antigenotoxic effects of grapefruit juice on the damage induced by benzo(a)pyrene and evaluation of its interaction with hepatic and intestinal Cytochrome P450 (Cyp) 1a1 | Q82734552 | ||
| Quantitative structure-activity relationships (QSARs) in inhibitors of various cytochromes P450: the importance of compound lipophilicity | Q94518970 | ||
| 7-Ethynylcoumarins: selective inhibitors of human cytochrome P450s 1A1 and 1A2. | Q35981085 | ||
| NADPH-dependent metabolism of 17beta-estradiol and estrone to polar and nonpolar metabolites by human tissues and cytochrome P450 isoforms. | Q36077440 | ||
| Cytochrome P450-mediated metabolism of estrogens and its regulation in human. | Q36236196 | ||
| Variation in CYP1A2 activity and its clinical implications: influence of environmental factors and genetic polymorphisms | Q37157901 | ||
| Estrogen metabolism and breast cancer: a risk model. | Q37403626 | ||
| Insights into the structure, function, and regulation of human cytochrome P450 1A2. | Q37585354 | ||
| 4-Hydroxylation of estrogens as marker of human mammary tumors | Q37649420 | ||
| Insights on cytochrome p450 enzymes and inhibitors obtained through QSAR studies | Q38032121 | ||
| Development of In Silico Protocols to Predict Structural Insights into the Metabolic Activation Pathways of Xenobiotics | Q38773543 | ||
| In silico studies of polyaromatic hydrocarbon inhibitors of cytochrome P450 enzymes 1A1, 1A2, 2A6, and 2B1. | Q39634811 | ||
| Fruits and vegetables protect against the genotoxicity of heterocyclic aromatic amines activated by human xenobiotic-metabolizing enzymes expressed in immortal mammalian cells | Q39667077 | ||
| Genetic polymorphisms in xenobiotic metabolism. | Q40515680 | ||
| Development of flavone propargyl ethers as potent and selective inhibitors of cytochrome P450 enzymes 1A1 and 1A2. | Q41919107 | ||
| Inhibition of cytochrome p450 enzymes by quinones and anthraquinones | Q41957293 | ||
| Structure-function relationships of inhibition of human cytochromes P450 1A1, 1A2, 1B1, 2C9, and 3A4 by 33 flavonoid derivatives | Q42023392 | ||
| QSAR models of cytochrome P450 enzyme 1A2 inhibitors using CoMFA, CoMSIA and HQSAR. | Q42084615 | ||
| Structure and drug inducibility of the human cytochrome P-450c gene | Q42104109 | ||
| A 3D model of CYP1B1 explains the dominant 4-hydroxylation of estradiol | Q42168050 | ||
| Inactivation of cytochrome P-450 by 2-isopropyl-4-pentenamide and other xenobiotics leads to heme-derived protein adducts. | Q42221739 | ||
| Computational prediction of binding affinity for CYP1A2-ligand complexes using empirical free energy calculations | Q44057105 | ||
| Arachidonic and eicosapentaenoic acid metabolism by human CYP1A1: highly stereoselective formation of 17(R),18(S)-epoxyeicosatetraenoic acid. | Q44812583 | ||
| Identification of the main human cytochrome P450 enzymes involved in safrole 1'-hydroxylation | Q45017802 | ||
| Metabolism of melatonin by human cytochromes p450. | Q45199304 | ||
| Comparative QSAR studies of CYP1A2 inhibitor flavonoids using 2D and 3D descriptors | Q45340702 | ||
| The alkaloid rutaecarpine is a selective inhibitor of cytochrome P450 1A in mouse and human liver microsomes | Q45712837 | ||
| A comparison of different QSAR approaches to modeling CYP450 1A2 inhibition. | Q45961899 | ||
| Classification of cytochrome P450 1A2 inhibitors and noninhibitors by machine learning techniques. | Q45964216 | ||
| A predominate role of CYP1A2 for the metabolism of nabumetone to the active metabolite, 6-methoxy-2-naphthylacetic acid, in human liver microsomes | Q46127887 | ||
| Expression of cytochrome P450 1A1 and its contribution to oxidation of a potential human carcinogen 1-phenylazo-2-naphthol (Sudan I) in human livers | Q46377584 | ||
| Theoretical quantitative structure-activity relationships of flavone ligands interacting with cytochrome P450 1A1 and 1A2 isozymes | Q46507745 | ||
| Inhibition of human and rat CYP1A1 enzyme by grapefruit juice compounds | Q46513074 | ||
| In vitro and in vivo evaluations of cytochrome P450 1A2 interactions with duloxetine | Q46728120 | ||
| Ortho-Methylarylamines as Time-Dependent Inhibitors of Cytochrome P450 1A1 Enzyme. | Q48065954 | ||
| Progress in tracing the evolutionary paths of cytochrome P450 | Q48658671 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P577 | publication date | 2017-07-08 | |
| P1433 | published in | Molecules | Q151332 |
| P1476 | title | Review of Ligand Specificity Factors for CYP1A Subfamily Enzymes from Molecular Modeling Studies Reported to-Date | |
| P478 | volume | 22 |
| Q64118886 | Adaptable Small Ligand of CYP1 Enzymes for Use in Understanding the Structural Features Determining Isoform Selectivity |
| Q92423266 | Breed, Diet, and Interaction Effects on Adipose Tissue Transcriptome in Iberian and Duroc Pigs Fed Different Energy Sources |
| Q57033826 | Carcinogens and DNA damage |
| Q57170659 | Correlation of tryptophan metabolites with connectivity of extended central reward network in healthy subjects |
| Q64253030 | Coumarins and P450s, Studies Reported to-Date |
| Q89908419 | Hepatic Differentiation of Marmoset Embryonic Stem Cells and Functional Characterization of ESC-Derived Hepatocyte-Like Cells |
| Q45943374 | QNA-Based Prediction of Sites of Metabolism. |
Search more.